A New Type of Medicine: Biotherapeutics Usher in a New Era

Antibody Data

Does Antibody Development Have a Data Problem?

Sophie Lutter, Ph.D.

Lab Thread

Cell Therapy

Overcoming Formulation and Fill/Finish Challenges for Cell Therapies

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Orthogonal Methods

Orthogonal Analytics: How Much Characterization Is Enough?

David Alvaro, Ph.D.

Pharma's Almanac

SmartScale

Phase-Appropriate CMC Requires a New Phase-Appropriate Manufacturing Model

Jesse McCool, Ph.D.

GBI Biomanufacturing

Data-Driven Mfg

Data-Driven Manufacturing and Digital Twins Across the Biologics Network

Jihyeon Oh; Hongwoo Joo

Samsung Biologics

CLD

Can Mammalian Cell-Line Engineering Become a High-Throughput Design Problem?

Pharma's Almanac

AAV Analytics

Advancing AAV Gene Therapies Through Analytical Innovation

Cynthia A. Challener, Ph.D.

Pharma's Almanac

CGT Release

Release Testing as a Cell and Gene Therapy Manufacturing Bottleneck

Pharma's Almanac

Bioprocessing

Bioprocessing and Capacity Trends: Growth Despite Continued Uncertainty

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Nonviral Delivery

Can Nonviral Delivery Change the Economics of Gene Therapy?

David Alvaro, Ph.D.

Pharma's Almanac

Viral Vectors

Gene Therapy Manufacturing After the Capacity Boom

David Alvaro, Ph.D.

Pharma's Almanac

DS + DP Integration

Integrating Drug Substance and Drug Product to Reduce Risk Across Development

Dörthe Ackenhausen

IDT Biologika